In This Section
CPM Webinar: Creating and Running an Ethical IP Law Firm Part 2 – Creating Firm Entity and Ownership; Determining Fees; Handling Client Money; Getting Paid; Record-Keeping Requirements; and Insurance
February 14, 2023 12:30 PM to 2:00 PM
Free for AIPLA Members!
Welcome to Part 2 of the Guide to creating and running an ethical IP Law Firm. This 90-minute webinar has something for those interested in starting their own practice as well as for those who may want to restructure or clean up an existing practice. Our two expert speakers will address a range of topics including the different types of organizational structures for law firms; who is allowed to own or partner in a law firm (answering questions for Patent Agents too!); common operational agreements; billing and determining your firm’s fees; trust account, record-keeping and banking practices; getting paid; and insurance considerations for your IP law firm.
Presented by: Emil Ali, McCabe Ali, LLP & Tracy Kepler, CNA
Add to:
News
-
AIPLA Files an Amicus Brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation
March 6, 2023
Arlington, VA. March 6, 2023 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation, an appeal arising from a $2.1 billion verdict and resulting judgment in a trade secret misappropriation case brought by Appian against Pegasystems. -
AIPLA Comments on Joint USPTO-FDA Collaboration Initiatives
February 28, 2023
Arlington, VA. February 28, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office (USPTO) in response to the USPTO’s Request for Comments on Joint USPTO-FDA Collaboration Initiatives. -
AIPLA Files an Amicus Brief at the Supreme Court in Amgen v. Sanofi
February 14, 2023
Arlington, VA. February 14, 2023 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief at the Supreme Court in Amgen v. Sanofi. -
AIPLA Comments on USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights
February 8, 2023
Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office’s ("The Office”) Request for Comments on possible initiatives of the Office to ensure the robustness and reliability of patent rights. -
AIPLA Comments on Joint Study on Non-Fungible Tokens (NFTs) and Intellectual Property
February 8, 2023
Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office and the United States Copyright Office in response to their joint study on the issues of intellectual property law and policy associated with non-fungible tokens (NFTs).